Clinical Trials Directory

Trials / Unknown

UnknownNCT02768909

Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Universidad Central de Venezuela · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Accepted

Summary

Determine the diagnostic accuracy for pulmonary tuberculosis in adults of the E-Nose in Venezuela.

Detailed description

Acronyms: Tuberculosis (TB) Receiver Operating Curve (ROC) Common Terminology Criteria for Adverse Effects (CTCAE) The aim of the study is to determine the diagnostic utility of the device 'Electronic Nose' for Pulmonary Tuberculosis. Prospective, Open, Three - Arm Controlled trial Study. Validation of the E-nose in urban settings to estimate the diagnostic accuracy of the E-nose using exhaled air in patients with Pulmonary TB in adults. The patients who qualified for the study, according to the inclusion criteria, after consenting, will be guided through and oriented survey for risk factors, then a complete physical exam, and after that, the patient will breathe for 5 minutes trough the device, which stores the patient information, that later will be download to a computer and will be send to the server's manufacturer company, in Netherlands. During and after the use of the device, we determine the adverse effects of the intervention, according to the CTCEA. The researchers use the sputum culture, which is the gold standard, to determine the diagnostic utility of the test. And, will compare the results with other tests currently perform as the regular diagnostic routine, such as Chest X-ray, sputum smear, and symptom based diagnosis. The patients in the experimental group are invited to come during the treatment phase, and will be asses the progress of the treatment, as well as another use of the device, at 5, 15, 30, 60 days after initiation of treatment, and will be compared the results of the device, with symptoms, x-ray changes, improvement of anthropometric findings, to determine the utility of the device to measure the response to treatment. Patient Registries will be keep in an electronic database, as well as handwriting history, with the backup copy in the records of the hospital in which the patient was admitted. auditoriae will be realised by the Ethics Comite in different time frames.

Conditions

Interventions

TypeNameDescription
DEVICEE-Nose1.They will be asked to perform a respiration for 5 minutes trough the E-Nose Device, with a nose clamp.
OTHERSurvey & Physical Exam2\. Perform a oriented survey for risk factors and a complete physical exam.
OTHERChest X-rayPerform anteroposterior chest X-ray
OTHERSputum SamplesSputum samples for Ziehl Neelsen smear and Culture in L-J.
DEVICEFollow Up 5 days after beginning of Tx.Patients will be asked to come 5 days after initiation of treatment, to perform another measurement with the device. Also will perform a Medical History, including Symptom based Survey, Physical Exam, Anthropometric measurement, to determine progress of treatment.
DEVICEFollow Up 15 days after beginning of Tx.Patients will be asked to come 15 days after initiation of treatment, to perform another measurement with the device. Also will perform a Medical History, including Symptom based Survey, Physical Exam, Anthropometric measurement, to determine progress of treatment.
DEVICEFollow Up 30 days after beginning of Tx.Patients will be asked to come 30 days after initiation of treatment, to perform another measurement with the device. Also will perform a Medical History, including Symptom based Survey, Physical Exam, Anthropometric measurement, to determine progress of treatment.
DEVICEFollow Up 60 days after beginning of Tx.Patients will be asked to come 60 days after initiation of treatment, to perform another measurement with the device. Also will perform a Medical History, including Symptom based Survey, Physical Exam, Anthropometric measurement, to determine progress of treatment.

Timeline

Start date
2015-01-01
Primary completion
2016-12-01
Completion
2017-02-01
First posted
2016-05-11
Last updated
2016-05-11

Locations

1 site across 1 country: Venezuela

Source: ClinicalTrials.gov record NCT02768909. Inclusion in this directory is not an endorsement.